Sarah H. Wild
Cardiovascular disease, cancer and mortality among people with type 2 diabetes and alcoholic or non-alcoholic fatty liver disease hospital admission
Wild, Sarah H.; Walker, Jeremy J.; Morling, Joanne R.; McAllister, David A.; Colhoun, Helen; Farran, Bassam; McGurnaghan, Stuart; McCrimmon, Rory; Read, Stephanie H.; Sattar, Naveed; Byrne, Christopher D.
Authors
Jeremy J. Walker
JOANNE MORLING JOANNE.MORLING@NOTTINGHAM.AC.UK
Professor of Public Health and Epidemiology
David A. McAllister
Helen Colhoun
Bassam Farran
Stuart McGurnaghan
Rory McCrimmon
Stephanie H. Read
Naveed Sattar
Christopher D. Byrne
Abstract
OBJECTIVE: To describe associations between alcoholic fatty liver disease (ALD) or non-alcoholic fatty liver disease (NAFLD) hospital admission and cardiovascular disease (CVD), cancer, and mortality in people with T2DM.
RESEARCH DESIGN AND METHODS: We performed a retrospective cohort study using linked population-based routine data from the diabetes register, hospital, cancer and death records for people aged 40-89 years, diagnosed with T2DM in Scotland 2004-2013 who had one or more hospital admission records. Liver disease and outcomes were identified using International Classification of Diseases codes. We estimated hazard ratios from Cox proportional hazards models, adjusted for key risk factors (aHRs).
RESULTS: There were 134,368 people with T2DM (1707 with ALD and 1452 with NAFLD) with mean follow-up of 4.3 years for CVD and 4.7 years for mortality. Among people with ALD, NAFLD or without liver disease hospital records respectively there were: 378, 320 and 21,873 CVD events, 268, 176 and 15,101 cancers and 724, 221 and 16,203 deaths. For ALD and NAFLD respectively, aHRs (95% CIs) compared to the group with no record of liver disease were: 1.59 (1.43, 1.76) and 1.70 (1.52, 1.90), for CVD; 40.3 (28.8, 56.5) and 19.12(11.71 31.2), for hepatocellular cancer (HCC); 1.28 (1.12, 1.47) and 1.10 (0.94, 1.29) for non-HCC cancer; 4.86 (4.50, 5.24) and 1.60 (1.40, 1.83) for all-cause mortality.
CONCLUSIONS: Hospital records of ALD or NAFLD are associated, to varying degrees, with increased risk of CVD, cancer and mortality in people with T2DM.
Citation
Wild, S. H., Walker, J. J., Morling, J. R., McAllister, D. A., Colhoun, H., Farran, B., …Byrne, C. D. (2018). Cardiovascular disease, cancer and mortality among people with type 2 diabetes and alcoholic or non-alcoholic fatty liver disease hospital admission. Diabetes Care, 41(2), https://doi.org/10.2337/dc17-1590
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 20, 2017 |
Online Publication Date | Nov 22, 2017 |
Publication Date | Feb 1, 2018 |
Deposit Date | Oct 23, 2017 |
Publicly Available Date | Nov 22, 2017 |
Journal | Diabetes Care |
Print ISSN | 0149-5992 |
Electronic ISSN | 1935-5548 |
Publisher | American Diabetes Association |
Peer Reviewed | Peer Reviewed |
Volume | 41 |
Issue | 2 |
DOI | https://doi.org/10.2337/dc17-1590 |
Public URL | https://nottingham-repository.worktribe.com/output/963004 |
Publisher URL | http://care.diabetesjournals.org/content/41/2/341 |
Contract Date | Oct 23, 2017 |
Files
cld_t2dm_final.pdf
(566 Kb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search